Pharma News News & Articles

221 Semen-Derived Enhancer of Viral Infection (SEVI) Binds Bacteria, Enhances Bacterial Phagocytosis by Macrophages, and Can Protect against Vaginal Infection by a Sexually Transmitted Bacterial Pathogen Antimicrobial Agents and Chemotherapy, May 15, 2013    Review Article

222 Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference Full Text Merck, May 15, 2013

223 Summit Examines State I.T. Initiatives, Challenges Full Text Health Data Management, May 15, 2013

224 Get Ready for New HL7 Standards Full Text Health Data Management, May 15, 2013

225 Merck for Mothers Launches Initiative in India to Reduce the Number of Women Dying During Pregnancy and Childbirth Full Text Merck, May 15, 2013

226 Naturally and synthetic smart composite biomaterials for tissue regeneration Advanced Drug Delivery Reviews, May 15, 2013    Review Article

227 Astellas: Reshaping research framework to enhance the ability to generate innovative drugs Full Text Astellas, May 15, 2013

228 Fda approves tarceva (erlotinib) tablets and cobas egfr mutation test for specific type of lung cancer Full Text Astellas, May 15, 2013

229 Assessing your asthma is key to taking control Full Text AstraZeneca, May 15, 2013

230 ARIAD Presents New Preclinical Data Showing Ponatinib is a Potent Inhibitor of RET and FGFR, Two Oncogenic Drivers of Non-Small Cell Lung Cancer Full Text ARIAD Pharmaceuticals, May 15, 2013

231 ARIAD to Present at UBS Global Healthcare Conference Full Text ARIAD Pharmaceuticals, May 15, 2013

232 ARIAD Presents New Preclinical Data Showing Ponatinib Overcomes Resistant Mutations in KIT, an Oncogenic Driver of Gastrointestinal Stromal Tumors Full Text ARIAD Pharmaceuticals, May 15, 2013

233 ARIAD Provides Update on Important Progress Being Made in R&D and Commercial Initiatives Full Text ARIAD Pharmaceuticals, May 15, 2013

234 ARIAD Presents New Preclinical Data Showing AP26113 Inhibits Clinically Relevant Mutants of ALK and ROS1 Full Text ARIAD Pharmaceuticals, May 15, 2013

235 ARIAD to Present at Bank of America Merrill Lynch Healthcare Conference Full Text ARIAD Pharmaceuticals, May 15, 2013

236 Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week 2013 Full Text Forest Laboratories, May 15, 2013

237 Covidien Announces Senior Notes Offering Full Text Covidien, May 15, 2013

238 Actemra Receives FDA Approval for Polyarticular Juvenile Idiopathic Arthritis Full Text BioPharm International, May 14, 2013

239 Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc. Full Text Bayer HealthCare Pharmaceuticals, May 14, 2013

240 Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period Full Text Bristol Myers-Squibb, May 14, 2013

1 Astellas pharma global development announces management reorganization Astellas, April 3, 2013    Free full text

2 Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States Abbott, April 16, 2013    Free full text

3 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Warner Chilcott, April 25, 2013    Free full text

4 FDA alerts providers to mattress cover safety risks American Hospital Association News, April 29, 2013    Free full text

5 Statement on FOSAMAX (alendronate sodium) Product Liability Trial Merck, March 12, 2013    Free full text

6 FDA alerts providers to drug product recalls American Hospital Association News, March 29, 2013    Free full text

7 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Taro Pharmaceuticals USA, April 15, 2013    Free full text

8 Alcon announces FDA approval of Simbrinza Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis, April 22, 2013    Free full text

9 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013    Free full text

10 CryoLife Receives FDA Clearance For Next Generation HeRO Device CryoLife, April 5, 2013    Free full text

11 US District Court rules one PULMICORT RESPULES (budesonide inhalation suspension) patent invalid and another patent not infringed AstraZeneca, April 2, 2013    Free full text

12 FDA approves Diclegis for pregnant women experiencing nausea and vomiting FDA Press Announcements, April 12, 2013    Free full text

13 CEL-SCI Corporation Provides Update on Phase III Clinical Trial CEL-SCI, April 24, 2013    Free full text

14 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Astellas, April 16, 2013    Free full text

15 Pfizer Issued Warning Letter for Italian Manufacturing Plant BioPharm International, April 12, 2013    Free full text

16 Valeant Pharmaceuticals Provides Update to Recent Event Valeant Pharmaceuticals International, April 5, 2013    Free full text

17 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 9, 2013    Free full text

18 Astellas pharma us, inc. names new president Astellas, April 3, 2013    Free full text

19 Medivation and astellas provide update on prevail Astellas, April 5, 2013    Free full text

20 Study: Tablets Can Effectively Read EEG Results Healthcare Informatics, April 5, 2013    Free full text